These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38468422)
1. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. Liao L; Li X; Chong T; Chen Q; Xu Z; Huang B; Chen M; Li H; Wei Z; Shao Y; Lu J; Pang R; Li X; Wang Y BJU Int; 2024 Jun; 133(6):760-769. PubMed ID: 38468422 [TBL] [Abstract][Full Text] [Related]
2. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Martin-Garcia M; Crampton J Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Sonmez R; Yildiz N; Alkan H Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson's Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson's disease using a self-contained wearable device. Smith MD; Tenison E; Drake MJ; Ben-Shlomo Y; Henderson EJ Trials; 2022 Oct; 23(1):912. PubMed ID: 36307874 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of a Transcutaneous Tibial Nerve Stimulation Device Use in Overactive Bladder Patients: A Pilot Study From a Single Tertiary Care Center. Li X; Li X; Zhou Z; Zhao H; Liao L Front Neurol; 2022; 13():872200. PubMed ID: 35528738 [TBL] [Abstract][Full Text] [Related]
6. Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson's disease: A randomized clinical trial. Araujo TG; Schmidt AP; Sanches PRS; Silva Junior DP; Rieder CRM; Ramos JGL Neurourol Urodyn; 2021 Jan; 40(1):538-548. PubMed ID: 33326648 [TBL] [Abstract][Full Text] [Related]
7. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis. Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial. Lashin AM; Eltabey NA; Wadie BS Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705 [TBL] [Abstract][Full Text] [Related]
9. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions? Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. Peters KM; Carrico DJ; Perez-Marrero RA; Khan AU; Wooldridge LS; Davis GL; Macdiarmid SA J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677 [TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome. Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial. Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Booth J; Connelly L; Dickson S; Duncan F; Lawrence M Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial. Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692 [TBL] [Abstract][Full Text] [Related]
15. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of transcutaneous electrical nerve stimulation combined with mirabegron therapy compared with mirabegron monotherapy for overactive bladder: a prospective randomized controlled study. Zhao L; Wu F; Wang J; Wang Y; Peng W; Chen Y World J Urol; 2024 Jun; 42(1):370. PubMed ID: 38847900 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541 [TBL] [Abstract][Full Text] [Related]